vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and NEW JERSEY RESOURCES CORP (NJR). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $440.9M, roughly 1.1× NEW JERSEY RESOURCES CORP). NEW JERSEY RESOURCES CORP runs the higher net margin — 27.8% vs 6.8%, a 21.0% gap on every dollar of revenue. On growth, NEW JERSEY RESOURCES CORP posted the faster year-over-year revenue change (22.8% vs -1.7%). Over the past eight quarters, NEW JERSEY RESOURCES CORP's revenue compounded faster (0.9% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

New Jersey Resources is an energy services holding company based in Wall Township, New Jersey. It is a Fortune 1000 company, and a member of the Forbes Platinum 400. New Jersey Natural Gas is its principal subsidiary.

MD vs NJR — Head-to-Head

Bigger by revenue
MD
MD
1.1× larger
MD
$493.8M
$440.9M
NJR
Growing faster (revenue YoY)
NJR
NJR
+24.5% gap
NJR
22.8%
-1.7%
MD
Higher net margin
NJR
NJR
21.0% more per $
NJR
27.8%
6.8%
MD
Faster 2-yr revenue CAGR
NJR
NJR
Annualised
NJR
0.9%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MD
MD
NJR
NJR
Revenue
$493.8M
$440.9M
Net Profit
$33.7M
$122.5M
Gross Margin
Operating Margin
9.9%
40.6%
Net Margin
6.8%
27.8%
Revenue YoY
-1.7%
22.8%
Net Profit YoY
10.5%
-6.7%
EPS (diluted)
$0.40
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
NJR
NJR
Q4 25
$493.8M
$440.9M
Q3 25
$492.9M
$188.3M
Q2 25
$468.8M
$234.8M
Q1 25
$458.4M
$569.2M
Q4 24
$502.4M
$359.0M
Q3 24
$511.2M
$265.7M
Q2 24
$504.3M
$209.9M
Q1 24
$495.1M
$433.2M
Net Profit
MD
MD
NJR
NJR
Q4 25
$33.7M
$122.5M
Q3 25
$71.7M
$15.1M
Q2 25
$39.3M
$-15.1M
Q1 25
$20.7M
$204.3M
Q4 24
$30.5M
$131.3M
Q3 24
$19.4M
$91.1M
Q2 24
$-153.0M
$-11.6M
Q1 24
$4.0M
$120.8M
Operating Margin
MD
MD
NJR
NJR
Q4 25
9.9%
40.6%
Q3 25
13.8%
21.5%
Q2 25
12.8%
-0.5%
Q1 25
7.0%
49.2%
Q4 24
7.8%
52.8%
Q3 24
6.6%
55.0%
Q2 24
-31.3%
2.8%
Q1 24
3.2%
39.3%
Net Margin
MD
MD
NJR
NJR
Q4 25
6.8%
27.8%
Q3 25
14.5%
8.0%
Q2 25
8.4%
-6.4%
Q1 25
4.5%
35.9%
Q4 24
6.1%
36.6%
Q3 24
3.8%
34.3%
Q2 24
-30.3%
-5.5%
Q1 24
0.8%
27.9%
EPS (diluted)
MD
MD
NJR
NJR
Q4 25
$0.40
$1.21
Q3 25
$0.84
$0.15
Q2 25
$0.46
$-0.15
Q1 25
$0.24
$2.02
Q4 24
$0.37
$1.31
Q3 24
$0.23
$0.91
Q2 24
$-1.84
$-0.12
Q1 24
$0.05
$1.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
NJR
NJR
Cash + ST InvestmentsLiquidity on hand
$375.2M
$2.4M
Total DebtLower is stronger
$570.5M
$3.3B
Stockholders' EquityBook value
$865.9M
$2.5B
Total Assets
$2.2B
$7.9B
Debt / EquityLower = less leverage
0.66×
1.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
NJR
NJR
Q4 25
$375.2M
$2.4M
Q3 25
$340.1M
$591.0K
Q2 25
$224.7M
$931.0K
Q1 25
$99.0M
$83.7M
Q4 24
$229.9M
$1.9M
Q3 24
$103.8M
$1.0M
Q2 24
$19.4M
$22.4M
Q1 24
$8.0M
$5.0M
Total Debt
MD
MD
NJR
NJR
Q4 25
$570.5M
$3.3B
Q3 25
$577.2M
$3.3B
Q2 25
$583.9M
$3.0B
Q1 25
$590.5M
$3.0B
Q4 24
$597.1M
$3.0B
Q3 24
$2.9B
Q2 24
$2.8B
Q1 24
$2.7B
Stockholders' Equity
MD
MD
NJR
NJR
Q4 25
$865.9M
$2.5B
Q3 25
$890.7M
$2.4B
Q2 25
$833.8M
$2.4B
Q1 25
$789.2M
$2.5B
Q4 24
$764.9M
$2.3B
Q3 24
$732.5M
$2.2B
Q2 24
$706.5M
$2.1B
Q1 24
$856.2M
$2.2B
Total Assets
MD
MD
NJR
NJR
Q4 25
$2.2B
$7.9B
Q3 25
$2.2B
$7.6B
Q2 25
$2.1B
$7.3B
Q1 25
$2.0B
$7.3B
Q4 24
$2.2B
$7.2B
Q3 24
$2.1B
$7.0B
Q2 24
$2.0B
$6.8B
Q1 24
$2.2B
$6.6B
Debt / Equity
MD
MD
NJR
NJR
Q4 25
0.66×
1.32×
Q3 25
0.65×
1.36×
Q2 25
0.70×
1.25×
Q1 25
0.75×
1.20×
Q4 24
0.78×
1.29×
Q3 24
1.31×
Q2 24
1.30×
Q1 24
1.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
NJR
NJR
Operating Cash FlowLast quarter
$114.1M
$26.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
0.22×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
NJR
NJR
Q4 25
$114.1M
$26.7M
Q3 25
$137.3M
$81.2M
Q2 25
$137.2M
$-28.9M
Q1 25
$-117.5M
$423.0M
Q4 24
$133.0M
$-9.0M
Q3 24
$91.8M
$64.5M
Q2 24
$107.0M
$24.3M
Q1 24
$-125.2M
$292.2M
Cash Conversion
MD
MD
NJR
NJR
Q4 25
3.39×
0.22×
Q3 25
1.91×
5.39×
Q2 25
3.49×
Q1 25
-5.66×
2.07×
Q4 24
4.36×
-0.07×
Q3 24
4.72×
0.71×
Q2 24
Q1 24
-31.03×
2.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

NJR
NJR

Residential$284.1M64%
Commercialand Industrial$53.4M12%
Firm Transportation$34.7M8%
Storage And Transportation ST Segment$28.1M6%
Home Services And Other HSO$16.0M4%
Energy Services ES Segment$12.8M3%
Installationand Maintenance$6.6M1%
Electricity$5.6M1%
Renewable Energy Certificates$3.7M1%
Interruptibleand Offtariff$2.4M1%

Related Comparisons